[
  {
    "title": "甘李药业(603087.SH)：A股定增申请获证监会受理",
    "href": "http://stock.jrj.com.cn/2022/12/29181037247056.shtml",
    "datetime": "2022-12-29 18:10:55",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：甘精胰岛素注射液获得巴基斯坦药品注册批件",
    "href": "http://stock.jrj.com.cn/2022/12/08165737198574.shtml",
    "datetime": "2022-12-08 16:57:42",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：Wintersweet以集中竞价累计减持20.22万股",
    "href": "http://stock.jrj.com.cn/2022/11/15190137141259.shtml",
    "datetime": "2022-11-15 19:01:13",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：明华创新持股比例从16.72%减至11.72%",
    "href": "http://stock.jrj.com.cn/2022/11/07182637117861.shtml",
    "datetime": "2022-11-07 18:26:28",
    "code": "603087"
  },
  {
    "title": "甘李药业集采“大杀价”单季亏超3亿 甘忠如地板价包揽8亿定增日赚2.6亿被指套利",
    "href": "http://stock.jrj.com.cn/2022/10/26115837084991.shtml",
    "datetime": "2022-10-26 11:58:30",
    "code": "603087"
  },
  {
    "title": "A股异动丨甘李药业一度逼近涨停 拟定增8.14亿元 实控人全额认购",
    "href": "http://stock.jrj.com.cn/2022/10/25111537080835.shtml",
    "datetime": "2022-10-25 11:15:36",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：拟推497万股的2022年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/10/24222937079850.shtml",
    "datetime": "2022-10-24 22:29:30",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：明华创新完成减持2%股份",
    "href": "http://stock.jrj.com.cn/2022/09/15182236997925.shtml",
    "datetime": "2022-09-15 18:22:00",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：明华创新持股比例从13.27%减至12.17%",
    "href": "http://stock.jrj.com.cn/2022/09/01175136963619.shtml",
    "datetime": "2022-09-01 17:51:42",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：GZR4中国Ⅰ期临床试验完成首例受试者给药",
    "href": "http://stock.jrj.com.cn/2022/09/01174936963552.shtml",
    "datetime": "2022-09-01 17:49:41",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)半年度净亏损1.98亿元、同比盈转亏",
    "href": "http://stock.jrj.com.cn/2022/08/25222736937739.shtml",
    "datetime": "2022-08-25 22:27:02",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：门冬胰岛素注射液获得哈萨克斯坦药品注册批件",
    "href": "http://stock.jrj.com.cn/2022/08/24175136931277.shtml",
    "datetime": "2022-08-24 17:51:47",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：335.978万股限售股将于8月15日解禁上市",
    "href": "http://stock.jrj.com.cn/2022/08/09175636883539.shtml",
    "datetime": "2022-08-09 17:56:47",
    "code": "603087"
  },
  {
    "title": "甘李药业：美国FDA同意GZR4进行I期临床试验",
    "href": "http://stock.jrj.com.cn/2022/08/08180836879715.shtml",
    "datetime": "2022-08-08 18:08:07",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：拟继续使用不超3.3亿元闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/08/08174736879586.shtml",
    "datetime": "2022-08-08 17:47:53",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：获得FDA同意GZR4进行I期临床试验的批准通知",
    "href": "http://stock.jrj.com.cn/2022/08/08174636879589.shtml",
    "datetime": "2022-08-08 17:46:13",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：Wintersweet拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2022/07/25180736840664.shtml",
    "datetime": "2022-07-25 18:07:04",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：GZR18中国II期临床试验完成首例受试者给药",
    "href": "http://stock.jrj.com.cn/2022/07/21155336831989.shtml",
    "datetime": "2022-07-21 15:53:37",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：注射剂GZR4获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/07/08171136794916.shtml",
    "datetime": "2022-07-08 17:11:19",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：GZR101中国I期临床试验完成首例受试者给药",
    "href": "http://stock.jrj.com.cn/2022/07/06163136787244.shtml",
    "datetime": "2022-07-06 16:31:58",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：磷酸西格列汀片获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2022/06/22161636749743.shtml",
    "datetime": "2022-06-22 16:16:23",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)2021年度权益分派10派3元 股权登记日为6月17日",
    "href": "http://stock.jrj.com.cn/2022/06/10162936719396.shtml",
    "datetime": "2022-06-10 16:29:48",
    "code": "603087"
  },
  {
    "title": "募投项目迟迟不动却热衷于投资股市，投资者对甘李药业十分不满！@丽尚国潮，网友喊你注意形象建个网站",
    "href": "http://stock.jrj.com.cn/2022/05/25193836678613.shtml",
    "datetime": "2022-05-25 19:38:58",
    "code": "603087"
  },
  {
    "title": "A股异动丨甘李药业跌约5% 股东明华创新减持1.06%股份",
    "href": "http://stock.jrj.com.cn/2022/05/24140236673724.shtml",
    "datetime": "2022-05-24 14:02:05",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：明华创新减持股份达1.06%",
    "href": "http://stock.jrj.com.cn/2022/05/23165236670639.shtml",
    "datetime": "2022-05-23 16:52:51",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：拟用于治疗糖尿病的GZR101获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/05/12161736642944.shtml",
    "datetime": "2022-05-12 16:17:52",
    "code": "603087"
  },
  {
    "title": "甘李药业2021年净利14.53亿同比增长18.04% 董事长甘忠如薪酬45.54万",
    "href": "http://stock.jrj.com.cn/2022/05/04115036554779.shtml",
    "datetime": "2022-05-04 11:50:40",
    "code": "603087"
  },
  {
    "title": "甘李药业2022年第一季度净利1.13亿同比下滑40.39% 销售费用同期增加",
    "href": "http://stock.jrj.com.cn/2022/05/03185036546059.shtml",
    "datetime": "2022-05-03 18:50:40",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：GZR18美国I期临床试验完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2022/03/10153334808616.shtml",
    "datetime": "2022-03-10 15:33:41",
    "code": "603087"
  },
  {
    "title": "甘李药业股东减持561.53万股 套现3.26亿 2021年第三季度公司净利4.99亿",
    "href": "http://stock.jrj.com.cn/2022/03/08195234542322.shtml",
    "datetime": "2022-03-08 19:52:46",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：GS Direct以集中竞价累计减持1%的股份",
    "href": "http://stock.jrj.com.cn/2022/03/08160234541302.shtml",
    "datetime": "2022-03-08 16:02:41",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：360.83万股限售股将于3月4日解禁上市",
    "href": "http://stock.jrj.com.cn/2022/02/28174334497368.shtml",
    "datetime": "2022-02-28 17:43:41",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：明华创新减持股份比例达到1.29%",
    "href": "http://stock.jrj.com.cn/2022/02/22172634435016.shtml",
    "datetime": "2022-02-22 17:26:22",
    "code": "603087"
  },
  {
    "title": "甘李药业大股东减持频繁 产品单一致业绩不稳",
    "href": "http://stock.jrj.com.cn/2022/02/22111634434298.shtml",
    "datetime": "2022-02-22 11:16:00",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：减持数过半 GS Direct已减持0.64%股份",
    "href": "http://stock.jrj.com.cn/2022/02/21185634423486.shtml",
    "datetime": "2022-02-21 18:56:12",
    "code": "603087"
  },
  {
    "title": "甘李药业股东明华创新减持484.46万股 套现3.41亿 2021年第三季度公司净利4.99亿",
    "href": "http://stock.jrj.com.cn/2022/02/14183234345613.shtml",
    "datetime": "2022-02-14 18:32:00",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：明华创新完成减持0.86%股份",
    "href": "http://stock.jrj.com.cn/2022/02/14163634344842.shtml",
    "datetime": "2022-02-14 16:36:17",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：25.9358万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/01/17180934165525.shtml",
    "datetime": "2022-01-17 18:09:10",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：GS Direct拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2022/01/13173834154648.shtml",
    "datetime": "2022-01-13 17:38:26",
    "code": "603087"
  },
  {
    "title": "甘李药业荣获金融界“金智奖” 2021年度中国上市公司杰出实业贡献奖",
    "href": "http://stock.jrj.com.cn/2022/01/05093934122671.shtml",
    "datetime": "2022-01-05 09:39:26",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：减持数过半 明华创新累计减持290.75万股",
    "href": "http://stock.jrj.com.cn/2021/12/28173334076876.shtml",
    "datetime": "2021-12-28 17:33:41",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：GZR18中国I期临床试验完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2021/12/10173533995145.shtml",
    "datetime": "2021-12-10 17:35:10",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：GZR18获得美国FDA药品临床试验批准",
    "href": "http://stock.jrj.com.cn/2021/12/06163933973964.shtml",
    "datetime": "2021-12-06 16:39:25",
    "code": "603087"
  },
  {
    "title": "甘李药业：在研药品GZR4临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/11/30161033944342.shtml",
    "datetime": "2021-11-30 16:10:42",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：糖尿病药GZR4获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/11/30160433944327.shtml",
    "datetime": "2021-11-30 16:04:50",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：6个产品及相关品规拟中选胰岛素专项集采",
    "href": "http://stock.jrj.com.cn/2021/11/28160833929560.shtml",
    "datetime": "2021-11-28 16:08:15",
    "code": "603087"
  },
  {
    "title": "甘李药业：拟中选第六批国家组织药品集中带量采购（胰岛素专项）",
    "href": "http://stock.jrj.com.cn/2021/11/28153733929476.shtml",
    "datetime": "2021-11-28 15:37:44",
    "code": "603087"
  },
  {
    "title": "A股异动 | 甘李药业涨7% 专项国采中标 门冬胰岛素最低报价19.98元",
    "href": "http://stock.jrj.com.cn/2021/11/26135033923229.shtml",
    "datetime": "2021-11-26 13:50:14",
    "code": "603087"
  },
  {
    "title": "甘李药业股东宽街博华减持561.54万股 套现3.86亿 第三季度公司净利4.99亿",
    "href": "http://stock.jrj.com.cn/2021/11/19204433882018.shtml",
    "datetime": "2021-11-19 20:44:59",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：宽街博华完成减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/11/19172733880694.shtml",
    "datetime": "2021-11-19 17:27:41",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：宽街博华累计减持股份达1.09%",
    "href": "http://stock.jrj.com.cn/2021/11/17184533867219.shtml",
    "datetime": "2021-11-17 18:45:23",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：减持数过半 宽街博华累计减持368.54万股",
    "href": "http://stock.jrj.com.cn/2021/11/17184333867213.shtml",
    "datetime": "2021-11-17 18:43:31",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：向激励对象首次授予1208.62万份股票期权",
    "href": "http://stock.jrj.com.cn/2021/11/10183233832563.shtml",
    "datetime": "2021-11-10 18:32:15",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：25.9358万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/11/08180333823879.shtml",
    "datetime": "2021-11-08 18:03:09",
    "code": "603087"
  },
  {
    "title": "甘李药业：前三季度净利润8.71亿元，同比增长26.99%",
    "href": "http://stock.jrj.com.cn/2021/10/29140333776772.shtml",
    "datetime": "2021-10-29 14:03:13",
    "code": "603087"
  },
  {
    "title": "甘李药业：第三季度净利4.99亿元 同比增长32%",
    "href": "http://stock.jrj.com.cn/2021/10/27223533764738.shtml",
    "datetime": "2021-10-27 22:35:41",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：第三季度净利增31.72%至4.99亿元",
    "href": "http://stock.jrj.com.cn/2021/10/27212333764426.shtml",
    "datetime": "2021-10-27 21:23:37",
    "code": "603087"
  },
  {
    "title": "A股异动 | 甘李药业(603087.SH)跌逾4% 股东明华创新、宽街博华拟合计减持不超2%公司股份",
    "href": "http://stock.jrj.com.cn/2021/10/22102133731750.shtml",
    "datetime": "2021-10-22 10:21:34",
    "code": "603087"
  },
  {
    "title": "甘李药业2名股东拟合计减持不超1123.08万股公司股份 上半年公司净利3.73亿",
    "href": "http://stock.jrj.com.cn/2021/10/21213633729735.shtml",
    "datetime": "2021-10-21 21:36:32",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：明华创新及宽街博华拟合计减持不超1123.08万股",
    "href": "http://stock.jrj.com.cn/2021/10/21184333728616.shtml",
    "datetime": "2021-10-21 18:43:26",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：宽街博华和GS Direct已通过集中竞价减持243.86万股",
    "href": "http://stock.jrj.com.cn/2021/10/19190333717702.shtml",
    "datetime": "2021-10-19 19:03:55",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：近日完成甘精胰岛素注射液糖尿病治疗研究的III期临床试验",
    "href": "http://stock.jrj.com.cn/2021/10/14160833691041.shtml",
    "datetime": "2021-10-14 16:08:17",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：明华创新已通过集中竞价累计减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/10/12171733679927.shtml",
    "datetime": "2021-10-12 17:17:55",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：拟推2021年股票期权激励计划",
    "href": "http://stock.jrj.com.cn/2021/09/27183033524945.shtml",
    "datetime": "2021-09-27 18:30:50",
    "code": "603087"
  },
  {
    "title": "甘李药业：赖脯胰岛素注射液获得白俄罗斯注册批件",
    "href": "http://stock.jrj.com.cn/2021/09/16200233446675.shtml",
    "datetime": "2021-09-16 20:02:32",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：赖脯胰岛素注射液获得白俄罗斯注册批件",
    "href": "http://stock.jrj.com.cn/2021/09/16183633446260.shtml",
    "datetime": "2021-09-16 18:36:52",
    "code": "603087"
  },
  {
    "title": "甘李药业副总经理Lawrence Allan Hill辞职 2020年薪酬为239.2万",
    "href": "http://stock.jrj.com.cn/2021/09/10185233416451.shtml",
    "datetime": "2021-09-10 18:52:41",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：3名股东减持期过半 合计减持614.66万股",
    "href": "http://stock.jrj.com.cn/2021/09/06162633392360.shtml",
    "datetime": "2021-09-06 16:26:31",
    "code": "603087"
  },
  {
    "title": "甘李药业2021年半年度净利3.73亿元 同比净利增加21.17%",
    "href": "http://stock.jrj.com.cn/2021/08/26193733326128.shtml",
    "datetime": "2021-08-26 19:37:28",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：上半年净利增21.17%至3.73亿元",
    "href": "http://stock.jrj.com.cn/2021/08/26185333325781.shtml",
    "datetime": "2021-08-26 18:53:23",
    "code": "603087"
  },
  {
    "title": "A股异动丨甘李药业(603087.SH)涨5.68% 赖脯胰岛素注射液获黎巴嫩注册批件",
    "href": "http://stock.jrj.com.cn/2021/08/25134533315705.shtml",
    "datetime": "2021-08-25 13:45:52",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：赖脯胰岛素注射液获黎巴嫩注册批件",
    "href": "http://stock.jrj.com.cn/2021/08/24174033310754.shtml",
    "datetime": "2021-08-24 17:40:37",
    "code": "603087"
  },
  {
    "title": "甘李药业股东Wintersweet减持11.16万股 套现1203.81万 一季度公司净利1.9亿",
    "href": "http://stock.jrj.com.cn/2021/08/20205333289322.shtml",
    "datetime": "2021-08-20 20:53:59",
    "code": "603087"
  },
  {
    "title": "甘李药业：甘精胰岛素原料药和注射液获巴拉圭注册批件",
    "href": "http://stock.jrj.com.cn/2021/08/20202433289095.shtml",
    "datetime": "2021-08-20 20:24:17",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：Wintersweet提前终止减持计划 已减持11.16万股",
    "href": "http://stock.jrj.com.cn/2021/08/20174333288075.shtml",
    "datetime": "2021-08-20 17:43:54",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：甘精胰岛素原料药和注射液获巴拉圭注册批件",
    "href": "http://stock.jrj.com.cn/2021/08/20174133288071.shtml",
    "datetime": "2021-08-20 17:41:44",
    "code": "603087"
  },
  {
    "title": "甘李药业涨停 胰岛素集采利空落地",
    "href": "http://stock.jrj.com.cn/2021/08/19105533278826.shtml",
    "datetime": "2021-08-19 10:55:10",
    "code": "603087"
  },
  {
    "title": "高瓴爱股甘李药业：为何半年雪崩50%？",
    "href": "http://stock.jrj.com.cn/2021/07/23200333141710.shtml",
    "datetime": "2021-07-23 20:03:56",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：减持数过半 明华创新已减持0.5%股份",
    "href": "http://stock.jrj.com.cn/2021/07/22165433135666.shtml",
    "datetime": "2021-07-22 16:54:08",
    "code": "603087"
  },
  {
    "title": "A股异动丨甘李药业(603087.SH)涨近5% 精蛋白人胰岛素混合注射液通过GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2021/07/22134933134843.shtml",
    "datetime": "2021-07-22 13:49:26",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)取得《药品GMP符合性检查结果的通知》",
    "href": "http://stock.jrj.com.cn/2021/07/20183233125277.shtml",
    "datetime": "2021-07-20 18:32:56",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：明华创新等股东拟减持合计不超3%股份",
    "href": "http://stock.jrj.com.cn/2021/06/28184433011243.shtml",
    "datetime": "2021-06-28 18:44:51",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：2.32亿股限售股将于6月29日上市流通",
    "href": "http://stock.jrj.com.cn/2021/06/23183832984188.shtml",
    "datetime": "2021-06-23 18:38:27",
    "code": "603087"
  },
  {
    "title": "甘李药业：公司2020年6月登录上交所主板 截至目前未进行过定向增发",
    "href": "http://stock.jrj.com.cn/2021/06/21173332970339.shtml",
    "datetime": "2021-06-21 17:33:13",
    "code": "603087"
  },
  {
    "title": "甘李药业：公司2020年投资活动产生的现金流量中投资支付的现金主要用于购买理财产品等投资",
    "href": "http://stock.jrj.com.cn/2021/06/11224532914301.shtml",
    "datetime": "2021-06-11 22:45:21",
    "code": "603087"
  },
  {
    "title": "甘李药业：在中国主要由于糖尿病的症状不明显因此相对知晓率低",
    "href": "http://stock.jrj.com.cn/2021/06/01182132858206.shtml",
    "datetime": "2021-06-01 18:21:31",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH) ：获得一款预混胰岛素的药品注册批件",
    "href": "http://stock.jrj.com.cn/2021/05/24190332811919.shtml",
    "datetime": "2021-05-24 19:03:28",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：2020年度拟10派4元 5月20日股权登记",
    "href": "http://stock.jrj.com.cn/2021/05/14170632755759.shtml",
    "datetime": "2021-05-14 17:06:27",
    "code": "603087"
  },
  {
    "title": "甘李药业：GLP-1RA类药物无法取代胰岛素在糖尿病治疗中的作用",
    "href": "http://stock.jrj.com.cn/2021/05/11195632737313.shtml",
    "datetime": "2021-05-11 19:56:17",
    "code": "603087"
  },
  {
    "title": "甘李药业2020年净利增长5.43% 董事长甘忠如薪酬45万",
    "href": "http://stock.jrj.com.cn/2021/04/15161832379807.shtml",
    "datetime": "2021-04-15 16:18:15",
    "code": "603087"
  },
  {
    "title": "甘李药业去年净利润增5%为12亿元 营业收入增16%",
    "href": "http://stock.jrj.com.cn/2021/04/15150932379408.shtml",
    "datetime": "2021-04-15 15:09:00",
    "code": "603087"
  },
  {
    "title": "甘李药业上市后首份年报成绩单出炉 胰岛素单一产品风险仍悬顶",
    "href": "http://stock.jrj.com.cn/2021/04/15091632377260.shtml",
    "datetime": "2021-04-15 09:16:42",
    "code": "603087"
  },
  {
    "title": "甘李药业首份年报：营收同增16.12% 研发驱动、国际化战略成效卓著",
    "href": "http://stock.jrj.com.cn/2021/04/14184332372970.shtml",
    "datetime": "2021-04-14 18:43:05",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：2020年度净利升5.43%至12.31亿元 拟10派4元",
    "href": "http://stock.jrj.com.cn/2021/04/14172232372456.shtml",
    "datetime": "2021-04-14 17:22:11",
    "code": "603087"
  },
  {
    "title": "甘李药业：山东临沂生产基地一期项目工程主体结构已经封顶",
    "href": "http://stock.jrj.com.cn/2021/04/08164432332706.shtml",
    "datetime": "2021-04-08 16:44:20",
    "code": "603087"
  },
  {
    "title": "甘李药业在研药物获EMA孤儿药资格认定",
    "href": "http://stock.jrj.com.cn/2021/04/07144732324876.shtml",
    "datetime": "2021-04-07 14:47:30",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：在研产品GLR2007获EC孤儿药资格认定",
    "href": "http://stock.jrj.com.cn/2021/04/06173432319610.shtml",
    "datetime": "2021-04-06 17:34:29",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：I类新药GZR18临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/03/23155032201718.shtml",
    "datetime": "2021-03-23 15:50:30",
    "code": "603087"
  },
  {
    "title": "中国首个自主研发的门冬胰岛素30注射液生产在即 甘李药业加速国产替代",
    "href": "http://stock.jrj.com.cn/2021/03/15104332134650.shtml",
    "datetime": "2021-03-15 10:43:59",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：门冬胰岛素30注射液(非最终灭菌产品)检查结果符合GMP标准",
    "href": "http://stock.jrj.com.cn/2021/03/12174232118412.shtml",
    "datetime": "2021-03-12 17:42:18",
    "code": "603087"
  },
  {
    "title": "甘李药业：GLR2007现正在美国进行一期临床试验",
    "href": "http://stock.jrj.com.cn/2021/02/23185632013733.shtml",
    "datetime": "2021-02-23 18:56:25",
    "code": "603087"
  },
  {
    "title": "甘李药业：甘忠如先生目前担任公司董事长、战略委员会主任委员、薪酬与考核委员会委员",
    "href": "http://stock.jrj.com.cn/2021/02/08083631867920.shtml",
    "datetime": "2021-02-08 08:36:44",
    "code": "603087"
  },
  {
    "title": "甘李药业：公司甘精胰岛素的欧美三期临床已经进入收尾阶段 目前进展顺利",
    "href": "http://stock.jrj.com.cn/2021/02/04154031848769.shtml",
    "datetime": "2021-02-04 15:40:25",
    "code": "603087"
  },
  {
    "title": "[甘李药业]甘李药业临床一期候选药物GLR2007获FDA快速通道审评资格认定",
    "href": "http://stock.jrj.com.cn/2021/01/29000031822589.shtml",
    "datetime": "2021-01-29 00:00:00",
    "code": "603087"
  },
  {
    "title": "[甘李药业]甘李药业在巴西取得重大商业化进展",
    "href": "http://stock.jrj.com.cn/2021/01/13000031682986.shtml",
    "datetime": "2021-01-13 00:00:00",
    "code": "603087"
  },
  {
    "title": "【龙虎榜】甘李药业1月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/11180831671367.shtml",
    "datetime": "2021-01-11 18:08:40",
    "code": "603087"
  },
  {
    "title": "[甘李药业]国际业务再加速——甘李药业门冬胰岛素获印尼原料药注册批件",
    "href": "http://stock.jrj.com.cn/2021/01/08000031653689.shtml",
    "datetime": "2021-01-08 00:00:00",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：门冬胰岛素获得印度尼西亚原料药注册批件",
    "href": "http://stock.jrj.com.cn/2021/01/07161131648251.shtml",
    "datetime": "2021-01-07 16:11:39",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)通过国家高新技术企业再次认定",
    "href": "http://stock.jrj.com.cn/2021/01/05162431634766.shtml",
    "datetime": "2021-01-05 16:24:35",
    "code": "603087"
  },
  {
    "title": "[甘李药业]甘李药业携新品亮相第二十届世界制药原料中国展",
    "href": "http://stock.jrj.com.cn/2020/12/31000031613867.shtml",
    "datetime": "2020-12-31 00:00:00",
    "code": "603087"
  },
  {
    "title": "[甘李药业]甘李药业甘精胰岛素注射液在黎巴嫩正式商业化",
    "href": "http://stock.jrj.com.cn/2020/12/21000031537797.shtml",
    "datetime": "2020-12-21 00:00:00",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)获门冬胰岛素30注射液《药品注册批件》",
    "href": "http://stock.jrj.com.cn/2020/12/14171431487800.shtml",
    "datetime": "2020-12-14 17:14:57",
    "code": "603087"
  },
  {
    "title": "[甘李药业]国内首家!甘李药业门冬胰岛素30注射液—锐秀霖30在中国获批上市",
    "href": "http://stock.jrj.com.cn/2020/12/14000031488333.shtml",
    "datetime": "2020-12-14 00:00:00",
    "code": "603087"
  },
  {
    "title": "甘李药业：门冬胰岛素30注射液药品注册处于“审批完毕-待制证”阶段",
    "href": "http://stock.jrj.com.cn/2020/12/06144931418185.shtml",
    "datetime": "2020-12-06 14:49:38",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：门冬胰岛素30注射液药品注册变更为“审批完毕-待制证”阶段",
    "href": "http://stock.jrj.com.cn/2020/12/06144431418160.shtml",
    "datetime": "2020-12-06 14:44:10",
    "code": "603087"
  },
  {
    "title": "[甘李药业]勇担道义回馈社会 甘李药业接连斩获CSR先锋奖、金紫荆奖",
    "href": "http://stock.jrj.com.cn/2020/12/03000031402114.shtml",
    "datetime": "2020-12-03 00:00:00",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：拟用于多种晚期实体肿瘤治疗的GLR2007临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2020/11/29154731367770.shtml",
    "datetime": "2020-11-29 15:47:10",
    "code": "603087"
  },
  {
    "title": "甘李药业：硬胶囊剂的临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2020/11/29152631367651.shtml",
    "datetime": "2020-11-29 15:26:13",
    "code": "603087"
  },
  {
    "title": "[甘李药业]北京市委书记蔡奇赴通州调研走进甘李药业 勉励企业加快创新药研发",
    "href": "http://stock.jrj.com.cn/2020/11/19000031318180.shtml",
    "datetime": "2020-11-19 00:00:00",
    "code": "603087"
  },
  {
    "title": "甘李药业前三季度净利6.86亿增长3.74% 财务费用下滑",
    "href": "http://stock.jrj.com.cn/2020/10/28090931148666.shtml",
    "datetime": "2020-10-28 09:09:23",
    "code": "603087"
  },
  {
    "title": "甘李药业：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/28001231145526.shtml",
    "datetime": "2020-10-28 00:12:24",
    "code": "603087"
  },
  {
    "title": "[甘李药业]甘李药业入选2019年度北京民营企业科技创新百强榜单",
    "href": "http://stock.jrj.com.cn/2020/10/28000031151417.shtml",
    "datetime": "2020-10-28 00:00:00",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：前三季度净利升3.74%至6.86亿元",
    "href": "http://stock.jrj.com.cn/2020/10/27181331143410.shtml",
    "datetime": "2020-10-27 18:13:42",
    "code": "603087"
  },
  {
    "title": "13连板后市值暴跌300多亿 甘李药业单品依赖模式能扛多久？",
    "href": "http://stock.jrj.com.cn/2020/09/15072530752305.shtml",
    "datetime": "2020-09-15 07:25:52",
    "code": "603087"
  },
  {
    "title": "甘李药业：在研产品获得美国FDA孤儿药资格认定",
    "href": "http://stock.jrj.com.cn/2020/09/10191030723087.shtml",
    "datetime": "2020-09-10 19:10:00",
    "code": "603087"
  },
  {
    "title": "甘李药业(603087.SH)：在研创新药“GLR2007”获得美国FDA孤儿药资格认定",
    "href": "http://stock.jrj.com.cn/2020/09/10181330722903.shtml",
    "datetime": "2020-09-10 18:13:39",
    "code": "603087"
  },
  {
    "title": "甘李药业：子公司秀霖针获得美国FDA医疗器械注册批准",
    "href": "http://stock.jrj.com.cn/2020/09/02165930661881.shtml",
    "datetime": "2020-09-02 16:59:00",
    "code": "603087"
  },
  {
    "title": "海外收入增近3倍 甘李药业上半年赚3亿元",
    "href": "http://stock.jrj.com.cn/2020/08/25034230579432.shtml",
    "datetime": "2020-08-25 03:42:50",
    "code": "603087"
  },
  {
    "title": "海外收入增近3倍 甘李药业上半年赚3亿",
    "href": "http://stock.jrj.com.cn/2020/08/25034030579431.shtml",
    "datetime": "2020-08-25 03:40:53",
    "code": "603087"
  },
  {
    "title": "甘李药业2020年上半年净利3.08亿增长14.92% 销售收入同比增长",
    "href": "http://stock.jrj.com.cn/2020/08/24224030578731.shtml",
    "datetime": "2020-08-24 22:40:44",
    "code": "603087"
  },
  {
    "title": "甘李药业：上半年实现净利润3.08亿元 同比增长14.92%",
    "href": "http://stock.jrj.com.cn/2020/08/24171930577032.shtml",
    "datetime": "2020-08-24 17:19:00",
    "code": "603087"
  },
  {
    "title": "甘李药业：抗肿瘤新药GLR2007海外启动I期临床研究首例患者入组",
    "href": "http://stock.jrj.com.cn/2020/07/31144030393262.shtml",
    "datetime": "2020-07-31 14:40:11",
    "code": "603087"
  },
  {
    "title": "中国首个自主研发门冬胰岛素产品生产在即 甘李药业门冬胰岛素通过GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2020/07/29094130370714.shtml",
    "datetime": "2020-07-29 09:41:25",
    "code": "603087"
  },
  {
    "title": "市值“摸高”千亿就掉头 都是高管集体辞职惹的祸？甘李药业急了：“掌门人”没跑",
    "href": "http://stock.jrj.com.cn/2020/07/28065130359090.shtml",
    "datetime": "2020-07-28 06:51:31",
    "code": "603087"
  },
  {
    "title": "甘李药业 \"胰岛素中茅台\" 财报真实可信？",
    "href": "http://stock.jrj.com.cn/2020/07/27111730353384.shtml",
    "datetime": "2020-07-27 11:17:20",
    "code": "603087"
  },
  {
    "title": "甘李药业调整管理团队 实施国际化战略",
    "href": "http://stock.jrj.com.cn/2020/07/27105530353173.shtml",
    "datetime": "2020-07-27 10:55:05",
    "code": "603087"
  },
  {
    "title": "甘李药业：新管理团队组建完成 加速迈向“世界一流”",
    "href": "http://stock.jrj.com.cn/2020/07/27104030353030.shtml",
    "datetime": "2020-07-27 10:40:11",
    "code": "603087"
  },
  {
    "title": "全新管理团队接任 甘李药业加速创新和国际化",
    "href": "http://stock.jrj.com.cn/2020/07/27091930352097.shtml",
    "datetime": "2020-07-27 09:19:00",
    "code": "603087"
  },
  {
    "title": "上市不足一个月 甘李药业掌门人甘忠如突然辞去总经理职务",
    "href": "http://stock.jrj.com.cn/2020/07/23073130319888.shtml",
    "datetime": "2020-07-23 07:31:38",
    "code": "603087"
  },
  {
    "title": "上市不足一个月 甘李药业掌门人突然辞去总经理职务",
    "href": "http://stock.jrj.com.cn/2020/07/22220930317412.shtml",
    "datetime": "2020-07-22 22:09:00",
    "code": "603087"
  },
  {
    "title": "新生代管理层登场 甘李药业加速聚焦研发及国际化战略",
    "href": "http://stock.jrj.com.cn/2020/07/20231330296179.shtml",
    "datetime": "2020-07-20 23:13:05",
    "code": "603087"
  },
  {
    "title": "甘李药业：管理团队迎新生代骨干 强化国际化战略与研发主导力度",
    "href": "http://stock.jrj.com.cn/2020/07/20214430295816.shtml",
    "datetime": "2020-07-20 21:44:00",
    "code": "603087"
  },
  {
    "title": "甘李药业部分高级管理人员辞职 均因个人原因",
    "href": "http://stock.jrj.com.cn/2020/07/20211030295677.shtml",
    "datetime": "2020-07-20 21:10:45",
    "code": "603087"
  },
  {
    "title": "【龙虎榜】甘李药业7月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/20180730294248.shtml",
    "datetime": "2020-07-20 18:07:12",
    "code": "603087"
  },
  {
    "title": "千亿医药龙头连续三跌停，这是什么风向？业绩超预期股名单来了，最强预增超25倍，外资大笔加仓10股",
    "href": "http://stock.jrj.com.cn/2020/07/20123730291828.shtml",
    "datetime": "2020-07-20 12:37:55",
    "code": "603087"
  },
  {
    "title": "次新股板块走弱 康华生物、甘李药业在开板首日即遭跌停",
    "href": "http://stock.jrj.com.cn/2020/07/16094930258375.shtml",
    "datetime": "2020-07-16 09:49:22",
    "code": "603087"
  },
  {
    "title": "上市两周市值破千亿后 甘李药业称孙公司胰岛素生产相关专利已失效",
    "href": "http://stock.jrj.com.cn/2020/07/16074430256157.shtml",
    "datetime": "2020-07-16 07:44:03",
    "code": "603087"
  },
  {
    "title": "十二连板甘李药业提示风险：公司孙公司名下胰岛素生产相关专利已于2018年3月31日失效",
    "href": "http://stock.jrj.com.cn/2020/07/15183130252314.shtml",
    "datetime": "2020-07-15 18:31:46",
    "code": "603087"
  },
  {
    "title": "【龙虎榜】甘李药业7月15日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/15181730252199.shtml",
    "datetime": "2020-07-15 18:17:55",
    "code": "603087"
  },
  {
    "title": "一人拿高管薪酬总额七成，甘李药业掌门人“离谱”高薪遭投诉",
    "href": "http://stock.jrj.com.cn/2020/07/10215830279566.shtml",
    "datetime": "2020-07-10 21:58:00",
    "code": "603087"
  },
  {
    "title": "一人拿高管薪酬总额七成，甘李药业掌门人“离谱”高薪遭投诉",
    "href": "http://stock.jrj.com.cn/2020/07/10215830208025.shtml",
    "datetime": "2020-07-10 21:58:00",
    "code": "603087"
  },
  {
    "title": "【龙虎榜】甘李药业7月10日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/10181530206633.shtml",
    "datetime": "2020-07-10 18:15:54",
    "code": "603087"
  },
  {
    "title": "【龙虎榜】甘李药业7月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/07181030169093.shtml",
    "datetime": "2020-07-07 18:10:00",
    "code": "603087"
  },
  {
    "title": "【龙虎榜】甘李药业7月2日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/02180930124175.shtml",
    "datetime": "2020-07-02 18:09:54",
    "code": "603087"
  },
  {
    "title": "中国首个新冠mRNA疫苗获批启动临床试验 甘李药业上市首日涨停 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/06/29180830088137.shtml",
    "datetime": "2020-06-29 18:08:06",
    "code": "603087"
  },
  {
    "title": "甘李药业登陆A股主板 未来将发力海外市场",
    "href": "http://stock.jrj.com.cn/2020/06/29155930087028.shtml",
    "datetime": "2020-06-29 15:59:00",
    "code": "603087"
  },
  {
    "title": "长情陪跑十年 启明创投眼中的甘李药业“有点甜”",
    "href": "http://stock.jrj.com.cn/2020/06/29075530082747.shtml",
    "datetime": "2020-06-29 07:55:00",
    "code": "603087"
  },
  {
    "title": "甘李药业：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/06/23225030002275.shtml",
    "datetime": "2020-06-23 22:50:00",
    "code": "603087"
  },
  {
    "title": "甘李药业中签号出炉 共有36180个",
    "href": "http://stock.jrj.com.cn/ipo/2020/06/17192029951036.shtml",
    "datetime": "2020-06-17 19:20:10",
    "code": "603087"
  },
  {
    "title": "过会26个月“修成正果” 甘李药业“一肩挑两家”的前董秘已离职",
    "href": "http://stock.jrj.com.cn/ipo/2020/06/17075829946371.shtml",
    "datetime": "2020-06-17 07:58:45",
    "code": "603087"
  },
  {
    "title": "中1签赚10万？新股近期太豪横 又是“高价+医药”",
    "href": "http://stock.jrj.com.cn/ipo/2020/06/16101329935501.shtml",
    "datetime": "2020-06-16 10:13:45",
    "code": "603087"
  },
  {
    "title": "甘李药业今日开启申购：发行定价63.32元 募资25亿元",
    "href": "http://stock.jrj.com.cn/ipo/2020/06/16095429935280.shtml",
    "datetime": "2020-06-16 09:54:15",
    "code": "603087"
  },
  {
    "title": "今日新股申购：甘李药业",
    "href": "http://stock.jrj.com.cn/2020/06/16085329934760.shtml",
    "datetime": "2020-06-16 08:53:00",
    "code": "603087"
  },
  {
    "title": "甘李药业今日申购 顶格申购需配市值12万元",
    "href": "http://stock.jrj.com.cn/ipo/2020/06/16080329934193.shtml",
    "datetime": "2020-06-16 08:03:42",
    "code": "603087"
  },
  {
    "title": "中1签赚10万？机会就在明天 又是“高价+医药”搭配",
    "href": "http://stock.jrj.com.cn/2020/06/15205629930201.shtml",
    "datetime": "2020-06-15 20:56:15",
    "code": "603087"
  },
  {
    "title": "甘李药业6月16日开启申购 拟募资以扩产和增强研发水平",
    "href": "http://stock.jrj.com.cn/2020/06/15203629930094.shtml",
    "datetime": "2020-06-15 20:36:00",
    "code": "603087"
  },
  {
    "title": "甘李药业6月16日申购宝典",
    "href": "http://stock.jrj.com.cn/ipo/2020/06/15145529927494.shtml",
    "datetime": "2020-06-15 14:55:09",
    "code": "603087"
  },
  {
    "title": "医疗器械板块领涨 甘李药业IPO获批并将于16日启动申购| 医资周报",
    "href": "http://stock.jrj.com.cn/2020/06/12175829909954.shtml",
    "datetime": "2020-06-12 17:58:51",
    "code": "603087"
  },
  {
    "title": "[财经天眼]胰岛素双雄会：毛利率比肩茅台 曾8亿行贿医生 甘李药业苦等800天终获批文， 通化东宝慌了？",
    "href": "http://stock.jrj.com.cn/2020/06/09132829879906.shtml",
    "datetime": "2020-06-09 13:28:36",
    "code": "603087"
  },
  {
    "title": "甘李药业IPO三大谜团待解 募投项目存风险",
    "href": "http://stock.jrj.com.cn/2018/05/08095724508256.shtml",
    "datetime": "2018-05-08 09:57:30",
    "code": "603087"
  },
  {
    "title": "甘李药业IPO硬伤：行贿主营单一研发“低配”",
    "href": "http://stock.jrj.com.cn/2018/04/20071024420264.shtml",
    "datetime": "2018-04-20 07:10:28",
    "code": "603087"
  },
  {
    "title": "甘李药业二次IPO过会 是否存商业贿赂仍是发审委关注焦点",
    "href": "http://stock.jrj.com.cn/ipo/2018/04/04091124349219.shtml",
    "datetime": "2018-04-04 09:11:00",
    "code": "603087"
  },
  {
    "title": "甘李药业IPO：“商业贿赂”阴影不散 能否过会存疑",
    "href": "http://stock.jrj.com.cn/ipo/2018/01/22134723984617.shtml",
    "datetime": "2018-01-22 13:47:46",
    "code": "603087"
  },
  {
    "title": "甘李药业股份有限公司首次公开发行股票招股说明书（申报稿2018年1月11日报送）",
    "href": "http://stock.jrj.com.cn/ipo/2018/01/16185923955955.shtml",
    "datetime": "2018-01-16 18:59:20",
    "code": "603087"
  },
  {
    "title": "为甘李药业上市让路 通化东宝拟4亿转让股权",
    "href": "http://stock.jrj.com.cn/2011/03/0105459317238.shtml",
    "datetime": "2011-03-01 05:45:33",
    "code": "603087"
  }
]